New York, Oct. 29, 2025 (GLOBE NEWSWIRE) -- CHIJET MOTOR COMPANY, INC. (NASDAQ: CJET) (“Chijet” or the “Company”) today announced that it will effect a one hundred (100)-for-one (1) share consolidation of its issued and unissued ordinary shares, par value US$0.3 per share on November 3, 2025. On September 24, 2025, the Company’s shareholders voted and approved at the annual general meeting (1) that the Company shall undertake an up to 100 for 1 share consolidation of the issued and unissued shares of the Co ...

Company Announcement No 52/2025Peberlyk 46200 AabenraaDenmarkTel +45 74 37 37 37Fax +45 74 37 35 36Sydbank A/SCVR No DK 12626509, Aabenraasydbank.dk29 October 2025 Sydbank, Arbejdernes Landsbank and Vestjysk Bank publish merger documents On 27 October 2025 Sydbank A/S (“Sydbank”), Aktieselskabet Arbejdernes Landsbank (“Arbejdernes Landsbank”) and Vestjysk Bank A/S (“Vestjysk Bank”) announced that they have entered into an agreement to merge the three banks (“the Merger”). Reference is made to Sydbank’s C ...

ATHENS, Greece, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Star Bulk Carriers Corp. (the "Company" or "Star Bulk") (Nasdaq: SBLK), a global leader in dry bulk shipping, today announced the publication of its 2024 Environmental, Social and Governance (ESG) Report. The 2024 ESG Report — Star Bulk’s seventh annual publication — provides a comprehensive overview of the Company’s sustainability strategy, performance, and future goals. Guided by its ESG Committee, Star Bulk continues to innovate and embed best practices a ...

AI and skill integration are enhancing the performance management processNEW YORK, Oct. 29, 2025 (GLOBE NEWSWIRE) -- WTW (NASDAQ:WTW), a leading global advisory, broking and solutions company, found that almost half of organizations believe performance management optimization would significantly increase productivity, yet most programs lack clarity and effectiveness. The study also found that more organizations are using AI and integrating skills as part of their performance management process. According to ...

The condensed interim financial statements of Eik fasteignafélag hf. for the period from 1 January to 30 September 2025 were approved by the Board of Directors and CEO on 29 October 2025. The main results from the Condensed Interim Financial Statements are as follows: Income from operations amounted to ISK 9,296 million Thereof, rental income amounted to ISK 7,980 million and has increased 8.9% between years. Operating profit before changes in fair value, sales gain and depreciation and amortization amount ...

Core Insights - Telitacicept has shown significant improvement in quality of life for patients with generalized myasthenia gravis (gMG), with 100% of patients achieving a ≥2-point improvement in Myasthenia Gravis Activities of Daily Living (MG-ADL) after 48 weeks [1][2] - The drug demonstrated sustained efficacy and a favorable safety profile, suggesting it may have a global best-in-disease profile for gMG [1][2] Study Results - In the 48-week open-label extension (OLE) study, patients on telitacicept achieved a mean reduction of -7.5 points in MG-ADL, while those who crossed over from placebo achieved a -6.3 point reduction [6] - At week 48, 96.2% of continuous telitacicept patients and 90.2% of crossover patients reached a ≥3-point improvement in MG-ADL [6] - The mean change in Quantitative Myasthenia Gravis (QMG) was -9.8 for continuous patients and -9.3 for crossover patients, with 94.2% and 90.2% achieving a ≥5-point improvement, respectively [6] Mechanism of Action - Telitacicept is a recombinant fusion protein that selectively inhibits BLyS (BAFF) and APRIL, two cytokines crucial for B cell and plasma cell survival, thereby reducing autoreactive B cells and autoantibody production [5] Regulatory Status - Telitacicept is already approved in China for systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and generalized myasthenia gravis (gMG) [7] - A global Phase 3 clinical trial for gMG is currently ongoing across 14 countries, aiming for potential approval in the United States, Europe, and Japan [7] Disease Context - Generalized myasthenia gravis (gMG) is a rare autoimmune neuromuscular disorder affecting approximately 90,000 people in the United States, 140,000 in Europe, and 29,000 in Japan, characterized by muscle weakness due to autoantibodies [8]

Core Insights - Argenx SE presented new data on the efficacy and safety of VYVGART for generalized myasthenia gravis (gMG) at the 2025 AANEM and MGFA meetings, highlighting its potential to improve patient outcomes across various gMG populations [1][2][3] Efficacy and Safety Data - The pivotal Phase 3 ADAPT SERON trial demonstrated that AChR-Ab seronegative gMG patients treated with VYVGART achieved a statistically significant improvement in MG-ADL total score compared to placebo, with a mean change of 3.35 points at week 4 [6] - Approximately 60% of VYVGART-treated gMG patients achieved minimal symptom expression (MSE), with 88% sustaining MSE for at least 4 weeks [5][6] - Real-world data indicated that over 70% of patients treated with VYVGART significantly reduced glucocorticoid use while maintaining clinical benefits [5][15] Treatment Impact - VYVGART is positioned as a targeted, effective, and safe treatment for gMG patients, regardless of autoantibody status, with ongoing studies contributing to redefining treatment standards [4][7] - The ADAPT Jr study showed that VYVGART improved outcomes in adolescents with gMG, addressing a high unmet need in this population [8] Regulatory Plans - Argenx plans to share the ADAPT SERON trial results with the U.S. FDA to seek an expansion of the VYVGART label to include adult AChR-Ab seronegative gMG patients across all subtypes [7] Long-term Outcomes - Long-term treatment with VYVGART was associated with substantial reductions in oral glucocorticoid use, with 72.5% of patients achieving meaningful tapering and an average daily dose reduction of over 50% after 18 months [15][26]

ROBESONIA, Pa., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Blaqclouds Inc. (OTC: BCDS), a leading Web3 infrastructure company, today announced the official launch of Deploy Launchpad, a full-suite, multi-chain token launch and ecosystem acceleration platform designed to empower developers, innovators, and organizations across the decentralized economy. Built to simplify the path from concept to capital, Deploy Launchpad integrates directly with Apollo Wallet and supports over 20 blockchains, including Ethereum (ETH) ...

Core Insights - AlphaTON Capital plans to invest significantly in GPU and data center resources to support the launch of Cocoon, a decentralized AI infrastructure announced by Telegram founder Pavel Durov [1][2][3] - Cocoon aims to provide secure and private AI inference through a distributed network, where developers will compensate GPU owners with TON cryptocurrency for processing requests [2][4] - The launch of Cocoon is seen as a pivotal moment in the integration of blockchain technology, data protection, and artificial intelligence [3][4] Company Strategy - AlphaTON Capital is committed to becoming a key contributor to the Cocoon ecosystem by deploying enterprise-grade GPU infrastructure to ensure sufficient computational capacity for major applications [3][4] - The company will utilize next-generation high-memory GPU models optimized for AI workloads across strategically located data centers, focusing on reliability and processing capacity [3][4] - AlphaTON Capital's participation highlights its strategic focus on the TON blockchain and Telegram-based AI applications, with the Cocoon network set to launch in November 2025 [4] Market Position - The Cocoon network is positioned to address a critical market need for privacy and security in AI, with AlphaTON Capital uniquely positioned as both a participant in the TON ecosystem and an infrastructure provider [4][6] - The company aims to provide institutional-grade exposure to the TON ecosystem and Telegram's extensive user base, leveraging its treasury strategy that includes direct token acquisition and strategic investments [6][7]

Core Insights - SKK Holdings Limited has appointed Chaince Securities LLC as its strategic advisor to develop a comprehensive tokenization and digital asset treasury strategy [1][2] - The collaboration aims to integrate digital asset capabilities into SKK's business model, enhancing capital efficiency and investor engagement [2][4] - SKK's CEO expressed confidence that this strategy will accelerate growth and add value for shareholders [3] Company Overview - SKK Holdings Limited is a civil engineering service provider based in Singapore, specializing in subsurface utility works [1][6] - The company has over 10 years of experience in various public utility projects, including power and telecommunication cable laying, water pipeline works, and sewer rehabilitation [6] Strategic Partnership - Chaince Securities will advise SKK on structuring its digital asset treasury, capital market strategy, and exploring staking and validator node opportunities [2][4] - This partnership reflects Chaince's expertise in bridging traditional finance with the digital asset economy [5][7]